世界の静脈内ヒト免疫グロブリン市場2022年:液体、粉末

◆英語タイトル:Global Intravenous Human Immunoglobulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書(GIR22MY8866)◆商品コード:GIR22MY8866
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2022年5月(※2025年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

静脈内ヒト免疫グロブリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の静脈内ヒト免疫グロブリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

静脈内ヒト免疫グロブリン市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・液体、粉末

用途別セグメントは次のように区分されます。
・病院、専門クリニック、その他

世界の静脈内ヒト免疫グロブリン市場の主要な市場プレーヤーは以下のとおりです。
・Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Tiantan Biological(Sinopharm)、Taibang Biologic Group

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、静脈内ヒト免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な静脈内ヒト免疫グロブリンメーカーの企業概要、2019年~2022年までの静脈内ヒト免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な静脈内ヒト免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別静脈内ヒト免疫グロブリンの販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの静脈内ヒト免疫グロブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での静脈内ヒト免疫グロブリン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および静脈内ヒト免疫グロブリンの産業チェーンを掲載しています。
・第13、14、15章では、静脈内ヒト免疫グロブリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Tiantan Biological(Sinopharm)、Taibang Biologic Group
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:液体、粉末
・用途別分析2017年-2028年:病院、専門クリニック、その他
・静脈内ヒト免疫グロブリンの北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・静脈内ヒト免疫グロブリンのヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・静脈内ヒト免疫グロブリンのアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・静脈内ヒト免疫グロブリンの南米市場規模2017年-2028年:ブラジル、アルゼンチン
・静脈内ヒト免疫グロブリンの中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Intravenous Human Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intravenous Human Immunoglobulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Intravenous Human Immunoglobulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intravenous Human Immunoglobulin include Baxter, Grifols, CSL, Octapharma, and Biotest, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intravenous Human Immunoglobulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid
Powder
Market segment by Application can be divided into
Hospital
Specialty Clinic
Others
The key market players for global Intravenous Human Immunoglobulin market are listed below:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Tiantan Biological(Sinopharm)
Taibang Biologic Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Human Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous Human Immunoglobulin, with price, sales, revenue and global market share of Intravenous Human Immunoglobulin from 2019 to 2022.
Chapter 3, the Intravenous Human Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Human Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intravenous Human Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravenous Human Immunoglobulin.
Chapter 13, 14, and 15, to describe Intravenous Human Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Intravenous Human Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous Human Immunoglobulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous Human Immunoglobulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Intravenous Human Immunoglobulin Market Size & Forecast
1.4.1 Global Intravenous Human Immunoglobulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intravenous Human Immunoglobulin Sales in Volume (2017-2028)
1.4.3 Global Intravenous Human Immunoglobulin Price (2017-2028)
1.5 Global Intravenous Human Immunoglobulin Production Capacity Analysis
1.5.1 Global Intravenous Human Immunoglobulin Total Production Capacity (2017-2028)
1.5.2 Global Intravenous Human Immunoglobulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous Human Immunoglobulin Market Drivers
1.6.2 Intravenous Human Immunoglobulin Market Restraints
1.6.3 Intravenous Human Immunoglobulin Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Intravenous Human Immunoglobulin Product and Services
2.1.4 Baxter Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Intravenous Human Immunoglobulin Product and Services
2.2.4 Grifols Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Intravenous Human Immunoglobulin Product and Services
2.3.4 CSL Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Intravenous Human Immunoglobulin Product and Services
2.4.4 Octapharma Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Intravenous Human Immunoglobulin Product and Services
2.5.4 Biotest Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Intravenous Human Immunoglobulin Product and Services
2.6.4 Kedrion Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Intravenous Human Immunoglobulin Product and Services
2.7.4 Hualan Bio Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Intravenous Human Immunoglobulin Product and Services
2.8.4 CNBG Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Product and Services
2.9.4 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Intravenous Human Immunoglobulin Product and Services
2.10.4 CBPO Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group Intravenous Human Immunoglobulin Product and Services
2.11.4 LFB Group Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL Intravenous Human Immunoglobulin Product and Services
2.12.4 BPL Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Tiantan Biological(Sinopharm)
2.13.1 Tiantan Biological(Sinopharm) Details
2.13.2 Tiantan Biological(Sinopharm) Major Business
2.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product and Services
2.13.4 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Taibang Biologic Group
2.14.1 Taibang Biologic Group Details
2.14.2 Taibang Biologic Group Major Business
2.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Product and Services
2.14.4 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intravenous Human Immunoglobulin Breakdown Data by Manufacturer
3.1 Global Intravenous Human Immunoglobulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intravenous Human Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intravenous Human Immunoglobulin
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Human Immunoglobulin Manufacturer Market Share in 2021
3.4.2 Top 6 Intravenous Human Immunoglobulin Manufacturer Market Share in 2021
3.5 Global Intravenous Human Immunoglobulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intravenous Human Immunoglobulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous Human Immunoglobulin Market Size by Region
4.1.1 Global Intravenous Human Immunoglobulin Sales in Volume by Region (2017-2028)
4.1.2 Global Intravenous Human Immunoglobulin Revenue by Region (2017-2028)
4.2 North America Intravenous Human Immunoglobulin Revenue (2017-2028)
4.3 Europe Intravenous Human Immunoglobulin Revenue (2017-2028)
4.4 Asia-Pacific Intravenous Human Immunoglobulin Revenue (2017-2028)
4.5 South America Intravenous Human Immunoglobulin Revenue (2017-2028)
4.6 Middle East and Africa Intravenous Human Immunoglobulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intravenous Human Immunoglobulin Sales in Volume by Type (2017-2028)
5.2 Global Intravenous Human Immunoglobulin Revenue by Type (2017-2028)
5.3 Global Intravenous Human Immunoglobulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intravenous Human Immunoglobulin Sales in Volume by Application (2017-2028)
6.2 Global Intravenous Human Immunoglobulin Revenue by Application (2017-2028)
6.3 Global Intravenous Human Immunoglobulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous Human Immunoglobulin Sales by Type (2017-2028)
7.2 North America Intravenous Human Immunoglobulin Sales by Application (2017-2028)
7.3 North America Intravenous Human Immunoglobulin Market Size by Country
7.3.1 North America Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
7.3.2 North America Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous Human Immunoglobulin Sales by Type (2017-2028)
8.2 Europe Intravenous Human Immunoglobulin Sales by Application (2017-2028)
8.3 Europe Intravenous Human Immunoglobulin Market Size by Country
8.3.1 Europe Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intravenous Human Immunoglobulin Sales by Type (2017-2028)
9.2 Asia-Pacific Intravenous Human Immunoglobulin Sales by Application (2017-2028)
9.3 Asia-Pacific Intravenous Human Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Intravenous Human Immunoglobulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intravenous Human Immunoglobulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intravenous Human Immunoglobulin Sales by Type (2017-2028)
10.2 South America Intravenous Human Immunoglobulin Sales by Application (2017-2028)
10.3 South America Intravenous Human Immunoglobulin Market Size by Country
10.3.1 South America Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
10.3.2 South America Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2017-2028)
11.2 Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2017-2028)
11.3 Middle East & Africa Intravenous Human Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intravenous Human Immunoglobulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intravenous Human Immunoglobulin
12.3 Intravenous Human Immunoglobulin Production Process
12.4 Intravenous Human Immunoglobulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intravenous Human Immunoglobulin Typical Distributors
13.3 Intravenous Human Immunoglobulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Intravenous Human Immunoglobulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intravenous Human Immunoglobulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Baxter Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Major Business
Table 5. Baxter Intravenous Human Immunoglobulin Product and Services
Table 6. Baxter Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Major Business
Table 9. Grifols Intravenous Human Immunoglobulin Product and Services
Table 10. Grifols Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Intravenous Human Immunoglobulin Product and Services
Table 14. CSL Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Octapharma Basic Information, Manufacturing Base and Competitors
Table 16. Octapharma Major Business
Table 17. Octapharma Intravenous Human Immunoglobulin Product and Services
Table 18. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biotest Basic Information, Manufacturing Base and Competitors
Table 20. Biotest Major Business
Table 21. Biotest Intravenous Human Immunoglobulin Product and Services
Table 22. Biotest Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Intravenous Human Immunoglobulin Product and Services
Table 26. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 28. Hualan Bio Major Business
Table 29. Hualan Bio Intravenous Human Immunoglobulin Product and Services
Table 30. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CNBG Basic Information, Manufacturing Base and Competitors
Table 32. CNBG Major Business
Table 33. CNBG Intravenous Human Immunoglobulin Product and Services
Table 34. CNBG Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 36. Shanghai RAAS Major Business
Table 37. Shanghai RAAS Intravenous Human Immunoglobulin Product and Services
Table 38. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CBPO Basic Information, Manufacturing Base and Competitors
Table 40. CBPO Major Business
Table 41. CBPO Intravenous Human Immunoglobulin Product and Services
Table 42. CBPO Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
Table 44. LFB Group Major Business
Table 45. LFB Group Intravenous Human Immunoglobulin Product and Services
Table 46. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. BPL Basic Information, Manufacturing Base and Competitors
Table 48. BPL Major Business
Table 49. BPL Intravenous Human Immunoglobulin Product and Services
Table 50. BPL Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Tiantan Biological(Sinopharm) Basic Information, Manufacturing Base and Competitors
Table 52. Tiantan Biological(Sinopharm) Major Business
Table 53. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product and Services
Table 54. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
Table 56. Taibang Biologic Group Major Business
Table 57. Taibang Biologic Group Intravenous Human Immunoglobulin Product and Services
Table 58. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Intravenous Human Immunoglobulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Intravenous Human Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Intravenous Human Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Intravenous Human Immunoglobulin Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Intravenous Human Immunoglobulin Production Site of Key Manufacturer
Table 64. Intravenous Human Immunoglobulin New Entrant and Capacity Expansion Plans
Table 65. Intravenous Human Immunoglobulin Mergers & Acquisitions in the Past Five Years
Table 66. Global Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 67. Global Intravenous Human Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 68. Global Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Intravenous Human Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 71. Global Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 72. Global Intravenous Human Immunoglobulin Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Intravenous Human Immunoglobulin Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Intravenous Human Immunoglobulin Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Intravenous Human Immunoglobulin Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 77. Global Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 78. Global Intravenous Human Immunoglobulin Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Intravenous Human Immunoglobulin Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Intravenous Human Immunoglobulin Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Intravenous Human Immunoglobulin Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 83. North America Intravenous Human Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 84. North America Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Intravenous Human Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 87. North America Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 88. North America Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 89. North America Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 90. Europe Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 91. Europe Intravenous Human Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 92. Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Intravenous Human Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 95. Europe Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 96. Europe Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 97. Europe Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Intravenous Human Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Intravenous Human Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 106. South America Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 107. South America Intravenous Human Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 108. South America Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Intravenous Human Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 111. South America Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 112. South America Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 113. South America Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Intravenous Human Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 122. Intravenous Human Immunoglobulin Raw Material
Table 123. Key Manufacturers of Intravenous Human Immunoglobulin Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Intravenous Human Immunoglobulin Typical Distributors
Table 127. Intravenous Human Immunoglobulin Typical Customers
List of Figures
Figure 1. Intravenous Human Immunoglobulin Picture
Figure 2. Global Intravenous Human Immunoglobulin Revenue Market Share by Type in 2021
Figure 3. Liquid
Figure 4. Powder
Figure 5. Global Intravenous Human Immunoglobulin Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Specialty Clinic
Figure 8. Others
Figure 9. Global Intravenous Human Immunoglobulin Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Intravenous Human Immunoglobulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Intravenous Human Immunoglobulin Sales (2017-2028) & (K Units)
Figure 12. Global Intravenous Human Immunoglobulin Price (2017-2028) & (US$/Unit)
Figure 13. Global Intravenous Human Immunoglobulin Production Capacity (2017-2028) & (K Units)
Figure 14. Global Intravenous Human Immunoglobulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Intravenous Human Immunoglobulin Market Drivers
Figure 16. Intravenous Human Immunoglobulin Market Restraints
Figure 17. Intravenous Human Immunoglobulin Market Trends
Figure 18. Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturer in 2021
Figure 19. Global Intravenous Human Immunoglobulin Revenue Market Share by Manufacturer in 2021
Figure 20. Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Intravenous Human Immunoglobulin Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Intravenous Human Immunoglobulin Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 24. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 25. North America Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 26. Europe Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 28. South America Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Intravenous Human Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 30. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 31. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 32. Global Intravenous Human Immunoglobulin Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 34. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 35. Global Intravenous Human Immunoglobulin Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 37. North America Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 38. North America Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 39. North America Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 40. United States Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 44. Europe Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 45. Europe Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 46. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 47. Germany Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 56. China Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 63. South America Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 64. South America Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 65. South America Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Intravenous Human Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Intravenous Human Immunoglobulin in 2021
Figure 77. Manufacturing Process Analysis of Intravenous Human Immunoglobulin
Figure 78. Intravenous Human Immunoglobulin Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の静脈内ヒト免疫グロブリン市場2022年:液体、粉末(Global Intravenous Human Immunoglobulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。